|
Keeping Up with Advances in MS: Cases in Diagnosis and Treatment, A Case-Based Roadmap for Improved Patient Outcomes in Multiple Sclerosis
Join Edward Fox, MD, PhD, and Matthew Schindler, MD, PhD, in an interactive case-based roadmap for improved outcomes in patients with MS. In addition to addressing diagnostic challenges, Drs. Fox and Schindler share their insights into integrating advances in the pharmacologic treatment of patients with MS, focusing on the safety and efficacy of targeted therapies. |
|
Managing Symptom Burden and Optimizing Treatment Outcomes in Myelofibrosis
Learn more about myelofibrosis risk factors, novel therapies to slow disease progression and reduce symptoms, and strategies to maintain quality of life in this comprehensive activity presented by John Mascarenhas, MD, Professor of Medicine at Mount Sinai Icahn School of Medicine. Start the activity now!
STATEMENT OF NEED
Myelofibrosis is a rare myeloproliferative neoplasm characterized by the buildup of scar tissue in the bone marrow, leading to decreased erythropoiesis, progressive bon... |
|
Paired Conversations: The Management of Patients With Hepatorenal Syndrome-Acute Kidney Injury: An International Perspective
This activity consists of 6 paired conversations with experts from Europe and the United States in the fields of hepatology, critical care, nephrology, and transplantation. During these paired conversations, the faculty explore revised diagnostic criteria, emerging treatment, and coordinating effective multidisciplinary care. In addition, the faculty panel collaboratively reviews a patient case where they share international perspectives on the nonpharmacological and pharmacological treatment ... |
|
|
New Opportunities for Improved Patient Outcomes in Graft-Versus-Host-Disease
STATEMENT OF NEED
Graft-versus-host disease (GHVD) is a common complication of allogeneic hematopoietic stem cell transplant (HSCT) and a major contributor to morbidity and mortality (DeFilipp et al, 2021; Malard et al, 2020). Acute GVHD occurs within 100 days of transplant and typically targets the skin, gastrointestinal tract, and liver (LLS, 2022). Chronic GVHD often presents within the first year following HSCT but may develop in subsequent years. It most commonly affects the skin; howe... |
|
|
Podcast: New Opportunities for Improved Patient Outcomes in Graft-Versus-Host-Disease
STATEMENT OF NEED
Graft-versus-host disease (GHVD) is a common complication of allogeneic hematopoietic stem cell transplant (HSCT) and a major contributor to morbidity and mortality (DeFilipp et al, 2021; Malard et al, 2020). Acute GVHD occurs within 100 days of transplant and typically targets the skin, gastrointestinal tract, and liver (LLS, 2022). Chronic GVHD often presents within the first year following HSCT but may develop in subsequent years. It most commonly affects the skin; howe... |
|
|
Oncology Data Advisor™: Aligning Treatment Goals and Value-Based Care in Newly Diagnosed Multiple Myeloma
STATEMENT OF NEED
Multiple myeloma is a clonal plasma cell malignancy characterized by several cytogenetic alterations. Treatment planning for individual patients is complicated by factors such as age, frailty, comorbidities, eligibility for autologous stem cell transplantation, and risk stratification (Kumar et al, 2022). Clinicians need to continually update their working knowledge of emerging data and consensus recommendations that can rationally inform clinical decision making. In Modul... |
|
|
A BRIGHTE New Option: Fostemsavir for Drug Resistant HIV
Combination antiretroviral therapy has changed the trajectory of outcomes for people living with HIV by dramatically reducing morbidity and mortality from the virus. While first line therapeutic options are effective disease management strategies for most patients, treatment options are quite limited for those who have developed multidrug resistant HIV. This application-based continuing pharmacy education activity will provide a ‘journal club format’ discussion for pharmacists and student ... |
|
|
Management of Large B-Cell Lymphomas: A Critical Update on Relapsed/Refractory Diffuse Large B-Cell Lymphoma and CAR T-Cell Therapy
TARGET AUDIENCE:
Hematologist-oncologists, pathologists, histologists, advanced practitioners, oncology nurses, pharmacists, and other healthcare professionals involved in the care of patients diagnosed with LBCL.
PROGRAM OVERVIEW:
In this activity, Jeremy Abramson, MD, highlights the significant disease burden of B-cell lymphomas, as well as the latest advances in therapeutics, and practical strategies for integrating novel therapies into practice through patient selection and supportive c... |
|
|
Comprehensive Sterile Compounding
June 15th - 17th, 2023
COMPREHENSIVE STERILE COMPOUNDING is an accredited 3-day, 20-hour (2.0 CEUs) practice-based course designed for pharmacists and technicians who are experienced in compounding.
Physicians and other healthcare professionals are welcome to attend. This course will also provide initial aseptic training for pharmacists and technicians required by their state board of pharmacy in order to compound sterile preparations.
Participants are instructed in the proper aseptic... |
|
|
Two Pediatric Bone Disorders in the Era of Disease Specific Therapies – When to Refer Patients and How to Treat XLH and HPP
Target Audience
This activity is designed to meet the educational needs of pediatricians in endocrinology, primary care, rheumatology, orthopedics, neurology, radiology, nephrology, neonatology, and other speciaties. Healthcare providers including geneticists and genetic counselors are included.
Program Overview
X-linked hypophosphatemia (XLH) and hypophosphotasia (HPP) are genetic metabolic bone diseases with recent treatment advances. This program will discuss when to refer and how ... |
|
|
Managing Overweight and Obese Patients
Obesity is a serious health problem and a common diagnosis in the United States, affecting over 40% of adults and 20% of adolescents (12-19 years). Obesity-related conditions include heart disease, type 2 diabetes, osteoarthritis, hypertension, certain types of cancer, and dyslipidemia, among others. Patients with obesity have annual medical costs that are $1,429 greater than those of people with a non-obese body mass index (BMI).
As we learn more about obesity, there is an increasing inter... |
|
|
A Heart of Gold to An Iron Fist: Compassion Fatigue & Resiliency
The term “compassion fatigue” was coined in 1995 to describe the emotional exhaustion resulting from continuous care-giving to those in need. While often used synonymously with “burnout,” the two terms are unique. Given the recent spike in sensitivity to mental health well-being, medical professionals are becoming more mindful of compassion fatigue and its impact on themselves, patient safety, professional satisfaction, and personal dealings. Medical literature recognizes the pervasive... |
|
|
WEBINAR: Veterinary Pharmacy Virtual Conference 2020 - On Demand
Earn up to 6.5 hours of continuing education focused on community veterinary pharmacy when you purchase the 2020 Veterinary Pharmacy Virtual Conference Bundle, originally presented June 26-27, 2020.
The ACVP Veterinary Pharmacy Virtual Conference is the only national conference designed exclusively for community veterinary pharmacies. Ideal for both new and established veterinary pharmacy practices, this conference is designed for pharmacists and pharmacy technicians and presents the lates... |
|
|
Pharmacy PrEP Education: A “How-to” Series Spanning Policy to Practice - Optimizing PrEP Access Through Advocacy
This activity will focus on medication therapy management protocols and their impact on prescription drug coverage policies. It also will look at PrEP access through a health equity lens and will include a review of the drug utilization review process, insurance models, and health impact analysis"considering the impact of each on patients and care. |
|
|
Community Conversations: Real-World Strategies for Overcoming Disparities in Immunotherapy Cancer Care
These powerful and captivating stories follow real-world patients on their immunotherapy journeys. Multidisciplinary cancer care clinicians also provide insightful perspectives on these stories. Experts review the latest data and guidance to frame ongoing disparities with immunotherapy access and share strategies to overcome barriers and broaden therapeutic opportunities for underserved patient populations. Don’t miss this powerful documentary-style education that will help you close the o... |
|
|
Therapeutic Interchange: Factors to Consider and Examples in Practice
For many reasons, including drug shortages, therapeutic interchange can be necessary. Pharmacists have the knowledge to make these recommendations, but don't always have the authority to do it without prior approval. That could be changing, and you should be ready. This course offers a step by step approach through decision tree analysis to implement therapeutic interchange when appropriate. Don't miss your opportunity to collaborate with prescribers for the best patient outcomes when their fi... |
|
|
Managing the Therapeutic Interchange Process
Drug shortages sometimes require pharmacists to dispense a different drug from the one prescribed. This course will equip you as a pharmacy technician to support this practice, called therapeutic interchange, through consistent documentation and effective communication between the pharmacy and prescribers. |
|
|
Clinical and Legal Considerations for Cannabis
The goal of this continuing education program is to educate attendees about the endocannabinoid system and cannabis pharmacology, including adverse effects, product choice, patient evaluation and discussion, risk versus benefit, and legal considerations for medical cannabis. |
|
|
Apixaban Steps Up to the Plate: The Use of Apixaban for Treatment of Venous Thromboemboli in Patients with Cancer
The incidence of venous thromboemboli (VTE) development in patients with cancer has been reported as much as four to seven-fold higher than that for non-cancer patients. Anticoagulation management remains challenging for these patients, due to the higher risk of recurrent VTE (despite anticoagulant therapy) and bleeding complications, compared to patients without cancer. This application-based continuing pharmacy education activity will provide a 'journal club format' discussion for pharmacist... |
|
|
Fundamental Compounding with Pharmacy Law
July 13th - 15th, 2023
FUNDAMENTAL COMPOUNDING is an accredited 3-day course that combines a 20-hour (2.0 CEUs) practice-based course with a 1 hour (0.1 CEU) knowledge-based course in Fundamental Compounding Law.
This course is designed for pharmacists, technicians, and students who are new to compounding or who have had training in the past but want a refresher. Physicians and other healthcare professionals are also welcome to attend.
CONTENT
This course provides didactic and hands-... |
|
|
HIV Emerging Trends in Prevention & Treatment- Florida Board Approved
This issue reviews recommended ARVs and focuses on the initial management of HIV in treatment-naïve adults, according to guidelines provided by the Department of Health and Human Services (DHHS). In addition, recommendations for ART in pregnancy are summarized and an update is included on the use of ARVs for PrEP and post-exposure prophylaxis (PEP), according to guidelines provided by the CDC.
This accredited program is targeted to pharmacists . |
|
|
Veterinary Compounding Essentials
July 28th - 29th, 2023
VETERINARY COMPOUNDING ESSENTIALS is an accredited 15-hour (1.5 CEUs) practice-based course that introduces pharmacists, technicians, and marketers to veterinary pharmacy compounding. The program provides fundamental techniques for effectively growing the veterinary compounding practice, including calculations, proper safety practices, hands-on compounding, and marketing.
Upon completion of this program, the participant will be able to:
• Demonstrate knowledge ... |
|
|
NAPRA Overview of Non-sterile Compounding Home Study
This 6.0 CE hour knowledge-based home study learning program is designed for pharmacists and pharmacy technicians who compound non-sterile preparations under the authority of NAPRA. At the conclusion of the course, participants will be familiar with the standards necessary to evaluate their practice, and able to develop service-related procedures and implement appropriate quality controls for both patients and compounding personnel, with a view to guaranteeing the overall quality and safety o... |
|
|
DOACs and Older Adults with NVAF (Part 1 of 3)
Direct acting oral anti-coagulants (DOACs) are a newer class of medications with emerging clinical recommendations and evidence for safe use. Cardiologists and pharmacists have key roles to play as part of the care team to help ensure efficacy and safety of DOACs within the severely ill patient population. |
|
|
DOACs and Patients with Renal Impairment (Part 2 of 3)
Direct acting oral anti-coagulants (DOACs) are a newer class of medications with emerging clinical recommendations and evidence for safe use. Cardiologists and pharmacists have key roles to play as part of the care team to help ensure efficacy and safety of DOACs within the severely ill patient population. |
|
|
OACs and Patients with Malignancies (Part 3 of 3)
Direct acting oral anti-coagulants (DOACs) are a newer class of medications with emerging clinical recommendations and evidence for safe use. Cardiologists and pharmacists have key roles to play as part of the care team to help ensure efficacy and safety of DOACs within the severely ill patient population. |
|
|
Is It Just Vision Change and Cataracts " Timely Diagnose and Treat Cerebrotendinous Xanthomatosis (CTX)
TARGET AUDIENCE:
This activity is designed to meet the educational needs of pediatricians, primary care physicians, opthalmologists, optometrists, neurologists, gastroenterologists, geneticists, genetic counselors, neonatologists, and other healthcare professionals.
PROGRAM OVERVIEW:
Vision change and cataracts are cardinal early presentations of cerebrotendinous xanthomatosis (CTX). This program will discuss disease recognition as well as diagnosis and treatment of CTX.
LEARNING OBJECTI... |
|
|
Ending the HIV Epidemic in the Southeast: Strategies to Increase PrEP Uptake in Rural and Underserved Communities Part 1: Getting to PrEP: Normalizing Sexual Health Conversations
Target Audience
This activity is designed specifically for primary care physicians, nurse practitioners, physician assistants, nurses, pharmacists, social workers, and other health professionals who serve patients in rural and underserved communities.
Program Overview
In rural and underserved areas, primary care clinicians are instrumental in identifying individuals at risk for HIV who may benefit from pre-exposure prophylaxis (PrEP). However, clinician discomfort when initiating and navi... |
|
|
Ending the HIV Epidemic in the Southeast: Strategies to Increase PrEP Uptake in Rural and Underserved Communities Part 2: Pre-Exposure Prophylaxis (PrEP): Putting HIV Prevention Into Practice
Target Audience
This activity is designed specifically for primary care physicians, nurse practitioners, physician assistants, nurses, pharmacists, social workers, and other health professionals who serve patients in rural and underserved communities.
Program Overview
Recently, the Centers for Disease Control and Prevention (CDC) released updated guidelines for the management of pre-exposure prophylaxis (PrEP) which include new recommendations for initial and follow-up HIV testing. In thi... |
|
|
Part 3: HIV Prevention - Optimizing PrEP Adherence and Engagement
Target Audience
This activity is designed specifically for primary care physicians, nurse practitioners, physician assistants, nurses, pharmacists, social workers, and other health professionals who serve patients in rural and underserved communities.
Program Overview
The burden of HIV disproportionately impacts rural and underserved parts of the country due to disparities in access to HIV care and prevention, including pre-exposure prophylaxis (PrEP). This activity, which is Part 3 of a ... |
|
|
Ending the HIV Epidemic in the Southeast: Strategies to Increase PrEP Uptake in Rural and Underserved Communities Part 4: Improving the PrEP Care Continuum in People Who Inject Drugs
Target Audience
This activity is designed specifically for primary care physicians, nurse practitioners, physician assistants, nurses, pharmacists, social workers, and other health professionals who serve patients in rural and underserved communities.
Program Overview
Although pre-exposure prophylaxis (PrEP) is widely recognized as an effective method for preventing HIV in at-risk populations, its uptake remains low in rural and underserved communities where stigma surrounding drug use an... |
|
|
Pharmacy PrEP Education: A “How-to” Series Spanning Policy to Practice - Providing PEP/PrEP in the Pharmacy Setting: A Comprehensive User Guide (Nevada Edition)
This activity will focus on the specific protocols, details, and policies necessary for pharmacists practicing in Nevada to implement postexposure prophylaxis (PEP) and PrEP. This state primer is best used as an additional resource to the monograph in this curriculum, Providing PEP/PrEP in the Pharmacy Setting: A Comprehensive User Guide. The monograph addresses all the clinical and behavioral aspects of HIV prevention, while the state primer will provide specific requirements from the state B... |
|
|
Pharmacy PrEP Education: A “How-to” Series Spanning Policy to Practice - Providing PEP/PrEP in the Pharmacy Setting: A Comprehensive User Guide (Oregon Edition)
This activity will focus on the specific protocols, details, and policies necessary for pharmacists practicing in Oregon to implement postexposure prophylaxis (PEP) and PrEP. This state primer is best used as an additional resource to the monograph in this curriculum, Providing PEP/PrEP in the Pharmacy Setting: A Comprehensive User Guide. The monograph addresses all the clinical and behavioral aspects of HIV prevention, while the state primer will provide specific requirements from the state B... |
|
|
Pharmacy PrEP Education: A “How-to” Series Spanning Policy to Practice - Providing PEP/PrEP in the Pharmacy Setting: A Comprehensive User Guide (Virginia Edition)
This activity will focus on the specific protocols, details, and policies necessary for pharmacists practicing in Virginia to implement postexposure prophylaxis (PEP) and PrEP. This state primer is best used as an additional resource to the monograph in this curriculum, Providing PEP/PrEP in the Pharmacy Setting: A Comprehensive User Guide. The monograph addresses all the clinical and behavioral aspects of HIV prevention, while the state primer will provide specific requirements from the state... |
|
|
Pharmacy PrEP Education: A “How-to” Series Spanning Policy to Practice - Providing PEP/PrEP in the Pharmacy Setting: A Comprehensive User Guide
This comprehensive electronic/downloadable monograph has been developed to specifically support the needs of pharmacists now challenged to come up to speed on guidelines and protocols for HIV preexposure and postexposure prophylaxis (PrEP and PEP). A number of states in the United States have expanded the pharmacy scope of practice and this continuing education activity will provide the necessary clinical information for initiating and monitoring PrEP and PEP treatment in a pharmacy setting. I... |
|
|
Better Education on Glomerulonephritis: Improving Knowledge of IgA Nephropathy
Nephrology experts Jai Radhakrishnan, MD, and Dana Rizk, MD, delve into the complex disease of immunoglobulin A nephropathy (IgAN), addressing unmet treatment needs and novel frontiers of therapy. They discuss IgAN as a chronic disease, reviewing its pathophysiologic basis, morbidity and mortality including significant reductions in health-related quality of life, existing treatment options, and evolving new targeted therapies. The experts review treatment strategies and highlight case studies... |
|
|
Non-sterile Compounding Home Study
This is a 10-hour knowledge-based home study learning program, designed for compounding pharmacists and technicians that will provide a broad overview of nonsterile compounding, including the regulations and standards that apply, along with discussions of each of the typical dosage forms prepared by compounders.
The calculations module provides detailed explanations and examples and is a guide to help develop proficiency in common pharmaceutical calculations. |
|
|
Compounding for the Veterinary Patient Home Study
In this 6-hour knowledge-based home study learning program, participants will review the regulations of veterinary medicine and recommendations for veterinary compounding, as well as the challenges in compounding for a veterinary patient. Participants will explore ways to help patients and owners by adjusting dosage strength, customizing dosage forms, and tailoring ingredient selection by animal species.
Participants will review important compounding principles, including the benefits an... |
|
|
2020 Immunization Update for Pharmacists
Recommendations regarding adult and pediatric immunizations are updated frequently. This course will discuss the new 2020 Advisory Committee on Immunization Practices (ACIP) recommendations. Included in the discussion will be influenza vaccine considerations in preparation for the 2020-2021 season and Centers for Disease Control and Prevention (CDC) guidelines for immunizing during a pandemic. Patient cases will be used to review recommended vaccines based on the most current immunization sche... |
|
|
2020 Immunization Update for Pharmacy Technicians
Recommendations regarding adult and pediatric immunizations are updated frequently. This course will discuss the new 2020 Advisory Committee on Immunization Practices (ACIP) recommendations. Included in the discussion will be influenza vaccine considerations in preparation for the 2020-2021 season and Centers for Disease Control and Prevention (CDC) guidelines for immunizing during a pandemic. Patient cases will be used to review recommended vaccines based on the most current immunization sche... |
|
|
Comprehensive Sterile Compounding
August 10th - 12th, 2023
COMPREHENSIVE STERILE COMPOUNDING is an accredited 3-day, 20-hour (2.0 CEUs) practice-based course designed for pharmacists and technicians who are experienced in compounding.
Physicians and other healthcare professionals are welcome to attend. This course will also provide initial aseptic training for pharmacists and technicians required by their state board of pharmacy in order to compound sterile preparations.
Participants are instructed in the proper asept... |
|
|
Cardiovascular Risk: Do Omega-3 Fatty Acids REDUCE-IT?
Recently, an emergence of non-statin alternatives including omega-3 fatty acid-based products have demonstrated reduction in important cardiovascular endpoints. Where do these agents fit in patient care? Join us this month for our Journal Club discussion on how icosapent ethyl compares to other non-statin alternatives and previous literature examining use of omega-3 fatty acids. |
|
|
Nontuberculous Mycobacterial Lung Disease: Strategies and Solutions for Real-World Management
TARGET AUDIENCE:
This activity was developed for pulmonologists, infectious diseases specialists, nurse practitioners, nurses, pharmacists, and other clinicians who have a role in the diagnosis and treatment of patients with nontuberculous mycobacterial lung disease.
PROGRAM OVERVIEW:
Join the faculty in this interactive, case-based dialogue about the real-world management of patients with MAC-LD. The faculty provide their insights to address challenges encountered in everyday clinical prac... |
|
|
Nontuberculous Mycobacterial Lung Disease: Strategies and Solutions for Real-World Management
In this case-based activity, Jennifer Faber-Gerling, RN, MS, CNS, NP-BC, David Griffith, MD, and Christina O’Connor, PharmD, BCPS, AAHIVP, provide their insight to address challenges encountered in everyday clinical practice. Their discussion highlights best practices in diagnosis and treatment initiation and modification based on guideline recommendations for MAC-LD, recent scientific and therapeutic advances, strategies for optimizing treatment adherence and completion, and the importance ... |
|
|
Rheumatoid Arthritis: A Pharmacist's Guide to Patient Management
With 1.3 million Americans currently diagnosed with Rheumatoid Arthritis, this specialty condition often finds itself being managed in multiple sites of care. This activity will provide updates on the disease, pathophysiology, treatment algorithms, and role of the pharmacist in the overall care and management of the RA patient. |
|
|
Rheumatoid Arthritis: A Pharmacy Technician's Guide to Patient Management
Patients diagnosed with Rheumatoid arthritis are one of the more frequent specialty conditions seen in practice. This activity will provide an overview of the disease state, identify common medications seen to treat patients, and how the pharmacy technician can get involved in managing patient care. |
|
|
Acute Ischemic Stroke: The Clock Is Ticking
Target Audience
This activity has been designed to address the educational needs of neurologists, emergency room physicians, and hospital clinicians (including hospitalists, nurse practitioners, PAs, and clinical pharmacists). It may also benefit other health care providers caring for patients at risk for acute ischemic stroke (AIS).
Program Overview
Faculty members who are expert in all aspects of the management of acute ischemic stroke use case scenarios to contextualize current gui... |
|
|
Fundamental Compounding with Pharmacy Law
September 7th - 9th, 2023
FUNDAMENTAL COMPOUNDING is an accredited 3-day course that combines a 20-hour (2.0 CEUs) practice-based course with a 1 hour (0.1 CEU) knowledge-based course in Fundamental Compounding Law.
This course is designed for pharmacists, technicians, and students who are new to compounding or who have had training in the past but want a refresher. Physicians and other healthcare professionals are also welcome to attend.
CONTENT
This course provides didactic and han... |
|
|
Can We Prevent C diff infection relapses with Vancomycin Prophlyaxis?
Clostridiodes difficile infections are a significant burden to patients and the healthcare community. Novel approaches are being investigated to help mitigate relapses. This application-based continuing pharmacy education will review recent infectious disease literature with a unique spin. Join us to learn how machine based learning can inform clinical trials and the recent updates on C diff infections. |
|
|
Practical Solutions to Prevent and Prepare for Severe Hypoglycemia
Episodes of hypoglycemia, including those that are severe, still occur despite new pharmacotherapies and the increased use of continuous glucose monitoring. Do you know which of your patients are at risk? Are they prepared with an active glucagon prescription? This activity helps you identify at risk patients and ensure they are prepared with access to glucagon. Included with the education are tools to educate patients and establish processes to improve hypoglycemia recognition and success wit... |
|